GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kunming Longjin Pharmaceutical Co Ltd (SZSE:002750) » Definitions » Cyclically Adjusted Price-to-FCF

Kunming Longjin Pharmaceutical Co (SZSE:002750) Cyclically Adjusted Price-to-FCF : 101.33 (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kunming Longjin Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-24), Kunming Longjin Pharmaceutical Co's current share price is ¥3.04. Kunming Longjin Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.03. Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 101.33.

The historical rank and industry rank for Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:002750' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 110.67   Med: 247.75   Max: 396
Current: 122.02

During the past years, Kunming Longjin Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 396.00. The lowest was 110.67. And the median was 247.75.

SZSE:002750's Cyclically Adjusted Price-to-FCF is ranked worse than
87.18% of 312 companies
in the Drug Manufacturers industry
Industry Median: 33.315 vs SZSE:002750: 122.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Kunming Longjin Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥-0.018. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.03 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kunming Longjin Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kunming Longjin Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Kunming Longjin Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 299.77

Kunming Longjin Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 269.58 257.12 322.15 299.77 274.92

Competitive Comparison of Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Kunming Longjin Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=3.04/0.03
=101.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kunming Longjin Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Kunming Longjin Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.018/115.2271*115.2271
=-0.018

Current CPI (Mar. 2024) = 115.2271.

Kunming Longjin Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.052 98.200 0.061
201409 0.005 98.900 0.006
201412 0.078 99.000 0.091
201503 0.009 99.900 0.010
201506 0.009 99.500 0.010
201509 0.037 100.500 0.042
201512 0.063 100.600 0.072
201603 0.072 102.200 0.081
201606 0.024 101.400 0.027
201609 0.035 102.400 0.039
201612 0.070 102.600 0.079
201703 -0.017 103.200 -0.019
201706 0.059 103.100 0.066
201709 0.026 104.100 0.029
201712 0.033 104.500 0.036
201803 -0.013 105.300 -0.014
201806 -0.020 104.900 -0.022
201809 0.000 106.600 0.000
201812 0.072 106.500 0.078
201903 -0.024 107.700 -0.026
201906 0.001 107.700 0.001
201909 0.024 109.800 0.025
201912 -0.010 111.200 -0.010
202003 -0.029 112.300 -0.030
202006 0.002 110.400 0.002
202009 -0.013 111.700 -0.013
202012 -0.036 111.500 -0.037
202103 -0.090 112.662 -0.092
202106 0.007 111.769 0.007
202109 0.012 112.215 0.012
202112 0.007 113.108 0.007
202203 -0.030 114.335 -0.030
202206 -0.033 114.558 -0.033
202209 -0.025 115.339 -0.025
202212 -0.011 115.116 -0.011
202303 -0.107 115.116 -0.107
202306 -0.021 114.558 -0.021
202309 -0.022 115.339 -0.022
202312 0.013 114.781 0.013
202403 -0.018 115.227 -0.018

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kunming Longjin Pharmaceutical Co  (SZSE:002750) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Kunming Longjin Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Kunming Longjin Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kunming Longjin Pharmaceutical Co (SZSE:002750) Business Description

Traded in Other Exchanges
N/A
Address
789 Lanmao Road, High-tech Zone, Majinpu, Kunming, CHN, 650503
Kunming Longjin Pharmaceutical Co Ltd is a pharmaceutical company. It develops, produces and sells natural botanical and chemical freeze-dried powder injections. It also has freeze-dried powder injection line. Its products include Chinese medicine, biochemical medicine, chemical medicine, cardio-cerebral vascular medicine, digestive system medicine, immune system medicine, vitamins, minerals, enteral and parenteral nutrition.
Executives
Fan Xian E Director
Zhang Cheng Rong Independent director

Kunming Longjin Pharmaceutical Co (SZSE:002750) Headlines

No Headlines